Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I really appreciate your post and your contagiousness also makes me enthusiastic, I will definitely stay where I am but sometimes I regret that I don't have those insights just like you so I often look at the whole thing from a different perspective
Again ))
I thought this was good news ???
i've read a lot but can't understand everything, it's a great result to read, i'm proud of our company, thanks for sharing
Buyers ))
good morning CELZDers we're going to see today, you start at the price of $6.37 an increase of 46,357.82% Could be worse
nothing has been announced about it yet and we don't even know how much the split is
you can ask a question here on this forum but it is rarely or never answered, at stocktwits almost every question is answered correctly, that is the big difference
EMA stops research into possible authorization of antibody cocktail
The European Medicines Agency (EMA) is ending its investigation into a possible market authorization for the corona medicine of the American pharmaceutical producer Eli Lilly. The company has withdrawn the antibody cocktail it had developed, the EMA reports in a press release.
AW 03-11-21, 12:53
Last update: 13:01
Source: BELGA
Eli Lilly developed a corona drug based on two monoclonal antibodies, bamlanivimab and etesevimab - call it an 'antibody cocktail'. The drug would be used to treat Covid-19 patients over the age of 12 who do not need supplemental oxygen, but who are at risk of serious illness.
Read also (3)
Five experts answer five questions about the fourth wave: “Getting rid of the virus? No. Never again"
PREMIUM
Five experts answer five questions about the fourth wave: “Getting rid of the virus? No. Never again"
The European medicines agency EMA started a so-called 'rolling review' in March 2021 with a view to market authorization for the medicine in the EU. That process is now halted, the EMA reports: Eli Lilly has withdrawn the drug himself.
In a letter to the drug agency, the company said it cannot meet the agency's demand to test the drug before it goes into production. In view of the demand from the European member states, production will no longer take place in the short term, it sounds like. The company can submit a new application for a rolling review and/or market authorization in the future, the medicines agency notes.
ADVERTISEMENT
Eli Lilly developed a corona drug based on two monoclonal antibodies, bamlanivimab and etesevimab.
Eli Lilly developed a corona drug based on two monoclonal antibodies, bamlanivimab and etesevimab. © AP
Use of antibodies
The EMA already issued a positive advice in March for the use of antibodies in corona patients. The fact that Eli Lilly is now withdrawing his antibody cocktail does not change that, the drug agency emphasizes. Member States are therefore still allowed to provide such medication for the treatment of corona patients.
The European Commission concluded another framework agreement in September for the joint purchase of Eli Lilly's Covid-19 drug. Eighteen Member States participated in the joint purchase of 220,000 treatments with the antibody cocktail.
I want to congratulate all ATLANTA BRAVES fans
????I don't really get it, sorry, does this have to do with CELZ??
I'm afraid you're right, would be a shame, I'm also concerned that if the FDA comes out with news that the stock isn't really going up, don't ask me why, it's a feeling
I wish you all a lot of fun with MAX VERSTAPEN in F1
is it Friday's news so huge that the price of the share will go up on Monday or is this just seen as something on the list of Mr Koos ??????????????????
Koos for president!!!
does anyone have any idea why the news came out so late??
I can't thank you enough for all your sleuthing and posting, great news
very nicely written, hats off to you, but you really can't get that big lid closed, I'm glad his name is above the post then you can go straight on, it's a waste of our time reading his scribbles, thanks again for you to post
and now ???what do you want to say???
is this data from RGBP? I can't find anything about that
I wonder if the list that Mr Koos wants to finish or that is necessary when selling the company
The Netherlands
Red ))
thanks for sharing, read the whole story on stocktwits, great post
in jail you have enough time
News !!!!!
very good find, thank you
3x 911
I completely agree, I see this as a setup for a quick buy out, if the big pharma don't bite quickly then smaller pharma will leave to get the big money
On Twitter:: $RGBP today was a classic move again the weak retail hands. The big sizes after the 8k were much larger than the average days before. Constant 250k-1mil buy orders processed with little to no movement on those buys. Big fish playing now.
Houdoe )
????I would have done the same as Mr Koos, give insight into what you are planning, so seek cooperation with all his patents (on paper) but in reality lure the big companies out of the tent so that no smaller pharmaceutical companies get involved go with the big profits of the patents ??????
can you indicate to me why he wants to continue after the sale with the money he would catch for this
how much time is there between a buyout announcement and the actual transfer???
Completely agree with you
after a good night's sleep I decided that this will not happen, otherwise he would never have let ONHP make this deal or am I wrong ???
so that's basically what i mean, why not grow up yourself, but everyone is trying to know but ?????